MECHANISM FOR NUTRITIONAL AND MOLECULAR REGULATION OF MAMMALIAN AUTOPHAGY
哺乳动物自噬的营养和分子调控机制
基本信息
- 批准号:12460056
- 负责人:
- 金额:$ 9.15万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This research project deals with clarifying the mechanism for nutritional, physiological and molecular regulation of mammalian autophagy, which mainly contributes to bulk proteolysis in the cell.Results obtained through the project for these 2 years are as follows : A. Nutritional role of AUTOPHAGY - The effect of rice protein, gluten and soy protein on hepatic in vivo proteolysis, measured by initial valine release from per fused rat liver, was compared. Feeding rice protein showed twice a faster proteolytic rate than that of soy protein, and a gluten diet e qualed a soy protein diet. The results led to the discovery the quality of dietary protein could af feet protein turnover rates in the liver.B. Regulatory mechanism of autophagic formation by amino acids - a) The "receptor" of amino acids on the hepatic plasma membrane was searched. The leucine analog, Leu-MAP, was employed as a ligand for putative "receptor". It was added with ASA and biotinylated to bind ASA with a target protei … More n by photoaffinity labeling and to purify the target by avidin resin, b) The unknown messenger molecule(s) for amino acid regulation was searched using α-toxin permeabilized hepatocytes. The recombinant α-toxin was prepared for steady effectiveness. By using this toxin,we could get repeatedly the original findings that the liver extract stimulated by regulatory amino acids showed a suppress!ve effect on proteolysis in a-toxin cell. The effectiveness was shown by that stimulated by leucine alone. More over, The extractable fraction by ethylacetate was also active, c) Possible involvement of protein phosphorylation in amino acid signaling - It turned out that the mTOR signaling pathway was not involved in the amino acid effectiveness on hepatic autophagy. However, a membrane protein LC3, involved in autophagic formation, was responded by amino acid signaling. The conversion of LC3 I to II form was suppressed by amino acids. It strongly suggested one of the target molecules of amino acid signaling is LC3.C. Development of in vitro assay method of autophagic membrane fusion - Using a p32 fragment of cytosolic enzyme, betaine homocysteine methyltransferase (BHMT) as a probe, an in vitro assay of membrane fusion between autophagosome and lysosome is to be established in order to identify cytosolic factors involved in this process. Less
本研究项目旨在阐明哺乳动物自噬的营养、生理和分子调控机制,自噬主要参与细胞内蛋白质的大量水解,两年来取得的成果如下:A.自噬的营养作用-大米蛋白、麸质和大豆蛋白对肝脏体内蛋白水解的影响,通过从每融合大鼠肝脏中初始缬氨酸释放来测量,进行了比较。大米蛋白的蛋白水解速率比大豆蛋白快一倍,谷蛋白饮食相当于大豆蛋白饮食。结果发现,膳食蛋白质的质量会影响肝脏中蛋白质的周转率。氨基酸自噬形成的调节机制- a)寻找肝质膜上氨基酸的“受体”。亮氨酸类似物Leu-MAP用作推定的“受体”的配体。加入阿萨并生物素化,使阿萨与靶蛋白结合。 ...更多信息 n通过光亲和标记并通过抗生物素蛋白树脂纯化靶标。B)使用α-毒素透化的肝细胞寻找用于氨基酸调节的未知信使分子。制备了具有稳定药效的重组α毒素。利用该毒素,我们可以反复得到最初的发现,即肝脏提取物对调节性氨基酸的刺激表现出抑制作用!ve对a-毒素细胞中蛋白质水解的影响。通过单独用亮氨酸刺激显示了有效性。此外,乙酸乙酯的可提取部分也是活性的。c)蛋白磷酸化可能参与氨基酸信号传导-结果表明mTOR信号传导途径不参与对肝自噬的氨基酸有效性。然而,膜蛋白LC 3,参与自噬形成,是由氨基酸信号。LC 3 I向II型的转化被氨基酸抑制。这强烈表明氨基酸信号传导的靶分子之一是LC 3.C。自噬体膜融合体外检测方法的建立--以胞浆酶甜菜碱同型半胱氨酸甲基转移酶(BHMT)的p32片段为探针,建立自噬体与溶酶体膜融合的体外检测方法,以鉴定参与该过程的胞浆因子。少
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KADOWAKI Motoni其他文献
KADOWAKI Motoni的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KADOWAKI Motoni', 18)}}的其他基金
Nutrient sensing and signaling mechanisms of hepatic and intestinal autophagy
肝和肠自噬的营养传感和信号机制
- 批准号:
23380074 - 财政年份:2011
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Search for Novel Functionalities of Amino Acids as Bio-regulatory Factors and Verification of Their Usefulness
寻找氨基酸作为生物调节因子的新功能并验证其有用性
- 批准号:
20248014 - 财政年份:2008
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Analysis of Regulatory Mechanism of Hepatic Autophagy and Its Contribution to Nutritional Science
肝自噬调控机制分析及其对营养科学的贡献
- 批准号:
14360072 - 财政年份:2002
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
STUDIES ON INTRACELLULAR REGULATORY FACTORS INVOLVED IN AUTOPHAGIC PROTEOLYSIS
自噬蛋白水解相关细胞内调控因子的研究
- 批准号:
09460061 - 财政年份:1997
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
肝受体类似物(Liver Receptor Homolog 1, LRH 1)在雌鼠生殖过程中的作用及其机制
- 批准号:31172040
- 批准年份:2011
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时指导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
- 批准号:
10103131 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
- 批准号:
MR/Y013751/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
Investigation of Endocrine-Disrupting Chemicals as Contributors to Progression of Metabolic Dysfunction Associated Steatotic Liver Disease (EDC-MASLD)
内分泌干扰化学物质对代谢功能障碍相关脂肪性肝病 (EDC-MASLD) 进展的影响的调查
- 批准号:
10092670 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
- 批准号:
10109933 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
HoloSurge:Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时引导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
- 批准号:
10109943 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
EU-Funded
Pluripotent stem cell derived hepatocytes for liver failure (PUSH for LIFE)
多能干细胞衍生的肝细胞治疗肝衰竭(PUSH for LIFE)
- 批准号:
MR/Z503940/1 - 财政年份:2024
- 资助金额:
$ 9.15万 - 项目类别:
Research Grant
Development of a novel human NASH model using human iPS cell-derived liver organoids
使用人类 iPS 细胞衍生的肝脏类器官开发新型人类 NASH 模型
- 批准号:
23K08025 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
- 批准号:
490038 - 财政年份:2023
- 资助金额:
$ 9.15万 - 项目类别:
Operating Grants